Avicanna (AVCNF, $0.24) was a top loser over the last three months, falling -1 to $0.24 per share. A.I.dvisor analyzed 244 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending September 26, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.